Testing effectiveness (Phase 2)WithdrawnNCT03803761
What this trial is testing
A New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer
Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+1 more
National Cancer Institute (NCI)